| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner | 10% Owner, See Remarks +3 more
5 companies
Chamath Palihapitiya last filed a Form 4 in November 2023, as Former CEO and Director at OPEN. The filings on record cover 5 companies. Chamath Palihapitiya's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Chamath Palihapitiya a middling insider score of 62/100, based on 35 past trades. Over a 12-month horizon, 54.3% of those trades were profitable, with an average 12-month return of +4.6%.
At the last filing, the largest reported position was 19,925,000 shares of SOFI.
Chamath Palihapitiya has 21 Form 4 filings on record from October 2019 to November 2023, across 5 companies: Former 10% Owner at Prokidney (PROK), 2022–2023; Clover Health Investments (CLOV), 2021; Former CEO and Director at SoFi Technologies (SOFI), 2021, and 2 more.
The 71 reported transactions were 48 open-market sales, 6 other transactions, 5 option exercises and 4 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $110.0M and 14 sales worth about $338.2M.
The largest open-market purchase was 10,000,000 shares of SPCE at an average $10.00 on October 25, 2019, about $100.0M.
The largest open-market sale was 6,200,000 shares of SPCE at an average $34.32 on March 3, 2021, about $212.8M.
None of the 12 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from November 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2023 | PROK Prokidney Corp. | Former 10% Owner | Sell | 7,256,367 | $1.31 | $9,498,584.40 | -100% | -10.8% | -6.0% | |
| Nov 17, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 752,800 | $1.31 | $987,945.79 | -12.7% | +5.8% | +40.1% | |
| Nov 14, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 576,700 | $1.56 | $897,871.85 | -8.9% | -13.2% | +36.2% | |
| Nov 8, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 209,833 | $1.60 | $334,948.12 | -3.1% | -24.2% | +15.2% | |
| Nov 3, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 405,400 | $1.70 | $688,099.69 | -5.7% | -19.9% | -3.7% | |
| Oct 31, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 391,400 | $1.65 | $645,514.11 | -5.2% | -9.2% | +3.1% | |
| Oct 26, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 321,473 | $1.77 | $567,572.88 | -4.1% | -11.7% | -4.6% | |
| Oct 23, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 447,500 | $2.01 | $899,962.99 | -5.4% | -23.5% | +3.4% | |
| Oct 18, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 447,043 | $2.70 | $1,205,389.82 | -5.1% | -36.0% | -10.8% | |
| Oct 13, 2023 | PROK Prokidney Corp. | 10% Owner | Sell | 486,863 | $2.86 | $1,391,816.82 | -5.3% | -43.0% | -33.9% |